Synthesis and biological activity of novel 4-nicotinoyl-1,7-di(pyridi-ne-3-yl)-3,5-diaryl heptane-1,7-dione under Claisen-Schmidt condensation

Key Points

• The novel compound exhibits significant biological activity across various tests, indicating potential medicinal uses.
• Synthesis involved a Claisen-Schmidt condensation to achieve the desired molecular structure and properties.
• Innovative methodologies enabled the formation of distinctly structured 4-nicotinoyl-1,7-di(pyridine-3-yl)-3,5-diaryl heptane-1,7-dione.
• Further investigations of this compound may lead to drug development and therapeutic improvements.